Biodexa Pharmaceuticals PLC (BDRX)
4.57
+0.17
(+3.86%)
USD |
NASDAQ |
Nov 22, 16:00
4.78
+0.21
(+4.60%)
After-Hours: 20:00
Biodexa Pharmaceuticals Market Cap: 2.654M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 2.654M |
| November 21, 2024 | 2.556M |
| November 20, 2024 | 2.236M |
| November 19, 2024 | 2.085M |
| November 18, 2024 | 2.120M |
| November 15, 2024 | 2.102M |
| November 14, 2024 | 2.823M |
| November 13, 2024 | 2.817M |
| November 12, 2024 | 2.916M |
| November 11, 2024 | 2.991M |
| November 08, 2024 | 3.125M |
| November 07, 2024 | 3.175M |
| November 06, 2024 | 3.357M |
| November 05, 2024 | 3.270M |
| November 04, 2024 | 3.299M |
| November 01, 2024 | 3.432M |
| October 31, 2024 | 3.572M |
| October 30, 2024 | 3.601M |
| October 29, 2024 | 3.868M |
| October 28, 2024 | 3.781M |
| October 25, 2024 | 3.665M |
| October 24, 2024 | 3.842M |
| October 23, 2024 | 4.106M |
| October 22, 2024 | 3.624M |
| October 21, 2024 | 3.473M |
| Date | Value |
|---|---|
| October 18, 2024 | 3.311M |
| October 17, 2024 | 3.409M |
| October 16, 2024 | 4.879M |
| October 15, 2024 | 2.910M |
| October 14, 2024 | 3.038M |
| October 11, 2024 | 3.049M |
| October 10, 2024 | 2.875M |
| October 09, 2024 | 2.782M |
| October 08, 2024 | 3.264M |
| October 07, 2024 | 3.462M |
| October 04, 2024 | 3.223M |
| October 03, 2024 | 3.489M |
| October 02, 2024 | 4.051M |
| October 01, 2024 | 4.443M |
| September 30, 2024 | 4.098M |
| September 27, 2024 | 4.176M |
| September 26, 2024 | 4.283M |
| September 25, 2024 | 4.234M |
| September 24, 2024 | 4.25M |
| September 23, 2024 | 3.976M |
| September 20, 2024 | 4.241M |
| September 19, 2024 | 5.314M |
| September 18, 2024 | 5.410M |
| September 17, 2024 | 5.532M |
| September 16, 2024 | 5.810M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
0.702M
Minimum
Mar 31 2023
45.60M
Maximum
Feb 04 2021
13.87M
Average
11.02M
Median
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 169.29M |
| NuCana PLC | 2.763M |
| TC BioPharm (Holdings) PLC | 0.3085M |
| Autolus Therapeutics PLC | 782.40M |
| Verona Pharma PLC | 3.176B |
Market Cap Related Metrics
| PS Ratio | 4.121 |
| Price to Book Value | 0.2405 |
| Price | 4.57 |
| Earnings Yield | -1.63K% |